US FDA approves Vertex's non-opioid painkiller-March 2024-www.financetom.com

US FDA approves Vertex's non-opioid painkiller

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves Vertex's non-opioid painkiller

Jan 30, 2025 3:06 PM

Jan 30 (Reuters) - The U.S. Food and Drug Administration has approved Vertex

Pharmaceuticals' ( VRTX ) drug to treat acute pain, the health regulator said on Thursday,

offering an alternative to addictive opioid painkillers that have fueled a national crisis.

Previous page： Solaris Resources Generates More than $39 Million in Combined Proceeds from Bought-Deal Offering, Private Placement Next page： Repare Therapeutics Doses First Patient in Camonsertib Monotherapy Non-Small Cell Lung Cancer Expansion Trial

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Solaris Resources Generates More than $39 Million in Combined Proceeds from Bought-Deal Offering, Private Placement

Jun 10, 2024

10:40 AM EDT, 06/10/2024 (MT Newswires) -- Solaris Resources ( SLSR ) said Monday it has closed on a CA$40.3 million ($29.3 million) bought-deal offering of slightly more than 8.2 million of the Canadian mining company's shares at CA$4.90 apiece. The stock sale included underwriters fully exercising their overallotment option to buy nearly 1.1 million shares. Separately, Solaris said it...

Repare Therapeutics Doses First Patient in Camonsertib Monotherapy Non-Small Cell Lung Cancer Expansion Trial

Jun 10, 2024

10:39 AM EDT, 06/10/2024 (MT Newswires) -- Repare Therapeutics ( RPTX ) said Monday the first patient was dosed in its camonsertib monotherapy non-small cell lung cancer expansion of a clinical trial. The trial will investigate the safety, tolerability and anti-tumor activity of camonsertib alone or in combinations, the company said. The expansion phase is expected to enroll up to...

Supreme Court seeks US government views on Honolulu climate suit against oil companies

Jun 10, 2024

WASHINGTON, June 10 (Reuters) - The U.S. Supreme Court on Monday asked President Joe Biden's administration to offer its views on a bid by Sunoco ( SUN ) and other oil companies to scuttle a lawsuit by Honolulu accusing them of deceiving the public about climate change. The request will delay a decision by the justices on whether to hear...

Royal Bank of Canada Obtains Regulatory Consent for Share Buyback

Jun 10, 2024

10:41 AM EDT, 06/10/2024 (MT Newswires) -- Royal Bank of Canada ( RY ) said on Monday that the Toronto Stock Exchange and the Office of the Superintendent of Financial Institutions gave the approval for a normal course issuer bid for the bank to buy up to 30 million of its common shares. Purchases under the normal course issuer bid...